2023 annual financial data
Skye Bioscience 2023 Operating margin
Skye Bioscience 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -34,735,173 USD and net income was -37,644,784 USD.
Operating cash flow was -13,952,178 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,735,173 USD
- Net income
- -37,644,784 USD
- Operating cash flow
- -13,952,178 USD